| Literature DB >> 35312813 |
Lisa Ernst1, Georgia Schilling2,3.
Abstract
The number of long-term survivors of malignant diseases is steadily increasing, which is due to the further development and optimization of multimodal therapy strategies and the mechanisms of new substance classes. These can now be combined with classical treatment methods or used sequentially. At the same time the number of patients who suffer from physical and psychosocial long-term consequences of cancer therapies or have to live with chronic side effects under the long-term therapies increases. Every therapy, whether radiation, chemotherapy, targeted therapy, or operation, has undesirable long-term side effects that contribute to the decrease of one's quality of life. These affect all parts of the body. As a result, patients can be heavily burdened. In oncology and in other disciplines involved in aftercare, these consequences must therefore be increasingly addressed and clarified and treatment strategies further developed. Unfortunately, there is still a considerable need for research in this area; moreover, there is a lack of clinical studies examining the evidence of a wide variety of holistic therapy methods.Entities:
Keywords: Aftercare; Cancer survivorship; Long-term and late side effects; Multimodal cancer therapy; Tertiary preventive care
Mesh:
Year: 2022 PMID: 35312813 DOI: 10.1007/s00103-022-03504-3
Source DB: PubMed Journal: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz ISSN: 1436-9990 Impact factor: 1.513